Modular network mechanism of CCN1-associated resistance to HSV-1-derived oncolytic immunovirotherapies for glioblastomas
Abstract Glioblastomas (GBMs) are the most common and lethal primary brain malignancy in adults. Oncolytic virus (OV) immunotherapies selectively kill GBM cells in a manner that elicits antitumor immunity. Cellular communication network factor 1 (CCN1), a protein found in most GBM microenvironments,...
Guardado en:
Autores principales: | Dileep D. Monie, Cristina Correia, Cheng Zhang, Choong Yong Ung, Richard G. Vile, Hu Li |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb6ba4dd71e340d2ac81300b41577f9c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Oncolytic virus-derived type I interferon restricts CAR T cell therapy
por: Laura Evgin, et al.
Publicado: (2020) -
The combination therapy of oncolytic HSV-1 armed with anti-PD-1 antibody and IL-12 enhances anti-tumor efficacy
por: Xin Xie, et al.
Publicado: (2022) -
Multi-Omics Analysis of Glioblastoma Cells’ Sensitivity to Oncolytic Viruses
por: Anastasiya V. Lipatova, et al.
Publicado: (2021) -
Interferon-independent STING signaling promotes resistance to HSV-1 in vivo
por: Lívia H. Yamashiro, et al.
Publicado: (2020) -
Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast Cancer
por: Alyssa Vito, et al.
Publicado: (2021)